Press Release
Hemotek Medical Inc. Receives a $2.9M Government Start-up Grant
HEALDSBURG, CA — Medical device start-up firm Hemotek Medical Incorporated has been awarded a 3-year, $2.9M Small Business Innovation Research (SBIR) award from the National Institutes of Health (specialty area, Diabetes, Digestive and Kidney Diseases), Hemotek CEO Charles Ventura announced today. Hemotek CSO Patrick J. Rousche, Ph.D. is the Principal Investigator. This Phase IIB SBIR…
Read More
Hemotek Medical Inc. names Charles Ventura CEO
Rohnert Park CA July 1, 2016 — Medical device start-up firm Hemotek Medical Incorporated has named Mr. Charles Ventura, formerly of Pfizer, legacy Hospira, as its new Chief Executive Officer. Mr. Ventura will assume the new role immediately, in correlation with the company’s newly announced receipt of a $1.4M Small Business Innovation Research award from the…
Read More
Hemotek Medical Inc. Receives a $1.4M Government Start-up Grant
ROHNERT PARK CA, JUNE 1, 2016. Medical device start-up firm Hemotek Medical Incorporated has been awarded a $1.4M Small Business Innovation Research award from the National Institutes of Health (specialty area, Diabetes, Digestive and Kidney Diseases). Hemotek Medical’s Chief Scientific Officer Patrick J. Rousche, Ph.D. is the Principal Investigator. This competitive Phase II award is…
Read More
Entrepreneurs look for connections at North Bay Innovation Week
Hemotek CEO Patrick J. Rousche points to three concrete benefits of housing his 2-year-old startup at the SoCo Nexus business incubator in Rohnert Park: Through it he found his web designer, computer networking consultant and intellectual property attorney. Hemotek CEO Patrick J. Rousche points to three concrete benefits of housing his 2-year-old startup at the…
Read More
Hemotek Medical Inc. Receives a $220,000 Government Start-up Grant
ROHNERT PARK CA, Aug 1, 2014. Medical device start-up firm Hemotek Medical Incorporated has been awarded a $220,000 Small Business Innovation Research award from the National Institutes of Health (specialty area, Diabetes, Digestive and Kidney Diseases). Hemotek CEO Patrick J. Rousche, Ph.D. is the Principal Investigator. This Phase I award will fund essential development of…
Read More